In the contemporary epidemiological landscape, Mycoplasma pneumoniae pneumonia (MPP) is witnessing a conspicuous surge within the pediatric demographic in China. Recent oscillations, marked by minor peaks and a distinct predilection toward younger age cohorts, have heightened apprehensions, particularly amidst a pronounced escalation in cases displaying heightened severity and refractoriness. This analytical endeavor seeks to meticulously unravel the intricate tapestry of the burgeoning MPP scenario, systematically dissecting the causative factors propelling this upward trajectory.Simultaneously, the distinctive characteristics of a younger age profile and an elevated proportion of severe and refractory cases prompt profound concerns regarding the prospective impact of respiratory diseases on the pediatric population in China in the ensuing years.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 14 print issues and online access
$259.00 per year
only $18.50 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Qu, J. et al. Epidemiological characterization of respiratory tract infections caused by Mycoplasma pneumoniae during epidemic and post-epidemic periods in North China, from 2011 to 2016. BMC Infect. Dis. 18, 335 (2018).
Jiang, Q., Yang, F., Peng, Y., Dong, X. & Ge, Y. Epidemiology and molecular identification of Mycoplasma pneumoniae associated with respiratory infections in Zhejiang Province, China, 2008-2017. J. Clin. Lab. Anal. 34, e23460 (2020).
Wang, X. et al. Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020. Emerg. Microbes Infect. 11, 1508–1517 (2022).
Zhenya, J. National Health and Health Commission: adhere to the same prevention and treatment of various respiratory diseases. Guang Ming Daily (In Chinese) (2023).
Yong, G. & Yangzi H. The drug resistance rate is over 90%. How to deal with Mycoplasma? (in Chinese) Jiefang Daily (2023).
Sweet, W., Yang, Y. & Zhongchongshan, M. J. Hospitals take many measures to cope with the peak of children’s visits in autumn and winter (in Chinese). Xinhua Daily (2023).
Tang, M. et al. Comparison of respiratory pathogens in children with community-acquired pneumonia before and during the Covid-19 pandemic. BMC Pediatr. 23, 535 (2023).
Zhao, H. et al. Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study. Lancet Infect. Dis. 21, 847–857 (2021).
Wang, N., Liu, W., Zhou, Y. & Liu, Y. In vitro activities of nemonoxacin and other antimicrobial agents against human mycoplasma and ureaplasmas isolates and their defined resistance mechanisms. Front. Microbiol. 10, 1890 (2019).
Chinese Thoracic Society Guidelines for diagnosis and treatment of adult community-acquired pneumonia in Chinese adults (2016 Edition) (in Chinese). Chin J Tubere Respir Dis 39, 253–279 (2016).
China NHCotPsRo. Guidelines for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023 Edition) (in Chinese). Int. J. Epidemiol. Infect. Dis. 79–85 (2023).
Ma, X. et al. Features of lung dysfunction in children with Mycoplasma pneumoniae pneumonia with different chest imaging findings (in Chinese). Chin. J. Contemp. Pediatr. 16, 997–1000 (2014).
Flanagan, F., Casey, A., Reyes-Múgica, M. & Kurland, G. Post-infectious bronchiolitis obliterans in children. Paediatr. Respir. Rev. 42, 69–78 (2022).
Castro-Rodriguez, J. A., Daszenies, C., Garcia, M., Meyer, R. & Gonzales, R. Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatr. Pulmonol. 41, 947–953 (2006).
Li, Y. N., Liu, L., Qiao, H. M., Cheng, H. & Cheng, H. J. Post-infectious bronchiolitis obliterans in children: a review of 42 cases. BMC Pediatr. 14, 238 (2014).
Funding
This research was funded by National Natural Science Foundation of China Youth Fund (82104928), General Program of China Postdoctoral Fund (No.2021M701123), and Research Nursery Project of Henan University of Traditional Chinese Medicine (MP2023-33).
Author information
Authors and Affiliations
Contributions
X.-y.X. drafted the manuscript. R.-y.Z. designed projects and provided guidance. S.-a.D. and Y.Z. collected the data in the article. B.-x.M. and X.Z. provided clinical guidance for the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Xie, Xy., Zhou, Ry., Ding, Sa. et al. Emerging trends and concerns in Mycoplasma pneumoniae pneumonia among Chinese pediatric population. Pediatr Res (2024). https://doi.org/10.1038/s41390-024-03049-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41390-024-03049-y